Inhibition of the Neuronal Insulin Receptor An in Vivo Model for Sporadic Alzheimer Disease?
Authors:
- 1 December 2000
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 920 (1) , 256-258
Abstract
Abstract: It has been hypothesized that a central event in the early pathogenesis of sporadic Alzheimer disease (SAD) is the dysfunction of the neuronal insulin receptor signal transduction. To prove this, this receptor was inhibited by a triplicate icv application of STZ. Insulin binding sites were upregulated as in SAD. With respect to glucose transport proteins, detailed investigations are necessary.Keywords
This publication has 8 references indexed in Scilit:
- Nitric oxide synthase does not mediate neurotoxicity after an i.c.v. injection of streptozotocin in the ratJournal of Neural Transmission, 2000
- Brain insulin and insulin receptors in aging and sporadic Alzheimer's diseaseJournal of Neural Transmission, 1998
- Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesisJournal of Neural Transmission, 1998
- Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.Behavioral Neuroscience, 1998
- Functional Alterations in Alzheimerʼs DiseaseJournal of Neuropathology & Experimental Neurology, 1995
- Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's diseaseAnnals of Neurology, 1994
- Oxidative energy metabolism in Alzheimer brainMolecular and Chemical Neuropathology, 1992
- Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: A cross-sectional comparison against advanced late-onset and incipient early-onset casesJournal of Neural Transmission, 1991